MOTION SICKNESS RELIEF- meclizine hcl tablet, film coated 
Shield Pharmaceuticals Corp

----------

Motion Sickness Relief

Drug Facts

Active ingredient (in each liquid-filled capsule)

Meclizine HCl 25 mg

Purpose

Antiemetic

Uses

for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness

Warnings

Do not usefor children under 12 years of age unless directed by a doctor.

Ask a doctor before use if you have

Ask a doctor or pharmacist before use if you are

taking sedatives or tranquilizers.

When using this product

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.1(800)222-1222

Directions

Other information

Inactive ingredients

colloidal silicon dioxide, D&C yellow #10 aluminum lake, lactose monohydrate, magnesium stearate, pregelatinized starch.

Questions or comments?

1-800-373-6981 (toll-free)

Shield Pharmaceuticals Corp.
Carle Place, NY 11514

PRINCIPAL DISPLAY PANEL

Compare to Dramamine® Less Drowsy active ingredient†

LESS DROWSY FORMULA

Motion Sickness Relief

Meclizine HCl, 25 mg

Antiemetic
Helps prevent nausea and dizziness due to motion sickness

For Ages 12 and Over

Motion Sickness Label

Motion Sickness Carton

MOTION SICKNESS RELIEF 
meclizine hcl tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83059-0007
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE25 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
D&C YELLOW NO. 10 ALUMINUM LAKE (UNII: CQ3XH3DET6)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
STARCH, CORN (UNII: O8232NY3SJ)  
Product Characteristics
ColoryellowScoreno score
ShapeROUNDSize8mm
FlavorImprint Code 44;403
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:83059-0007-11 in 1 PACKAGE12/06/2023
115 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00212/06/2023
Labeler - Shield Pharmaceuticals Corp (118724924)

Revised: 12/2023
Document Id: 0bf59ea9-df41-d9da-e063-6394a90acbf4
Set id: 9b5ad2ca-a47b-434a-97b5-8f729740d4ee
Version: 2
Effective Time: 20231207
 
Shield Pharmaceuticals Corp